Conduction slowing is the major in vivo effect of sodium channel blocking drugs. Although this action may promote arrhythmia suppression, apparently paradoxical arrhythmia aggravation does occur. The latter outcome is most frequently seen during treatment with the class IC agents such as encainide or flecainide, which are potent depressors of conduction even at usual plasma concentrations and heart rates. Anecdotal reports in patients with such drug toxicity have suggested a beneficial effect of sodium lactate or NaHCO3 administration. The purpose of this study, therefore, was to examine the changes induced by sodium loading on the electrophysiologic properties of the canine ventricle pretreated with a class IC drug. Thirty dogs received loading and maintenance infusions of O-desmethyl encainide (ODE), an encainide metabolite that as a sodium channel blocker is approximately 10 times more potent than the parent drug. Interventions were administered during the maintenance phase when stable plasma ODE concentrations of 448±68 (SEM) ng/ml were present, and QRS was prolonged from 62±1 to 89+2 msec, and HV was prolonged from 28±1 to 50±1 msec. NaHCO3 (5 meq/kg during 1 minute) shortened QRS from 92±6 to 76±3 msec and shortened HV from 44±3 to 37±3 msec within 10 minutes (both p<0.01). NaHCO3 also significantly prolonged endocardial monophasic action potential duration from 231±22 to 272 +33 msec and decreased serum [K+] from 3.8+0.2 to 3.0+±0.2 meq/l, but it did not alter plasma ODE concentration. Administration of a second sodium salt, NaCI (5 meq/kg during 1 minute), produced similar efects. Respiratory alkalosis did not alter QRS, HV, or monophasic action potential duration, whereas osmotic loading with mannitol increased QRS, HV, and monophasic action potential duration. Infusion of KCI to maintain serum [K'] constant during NaCI treatment blunted the changes in monophasic action potential duration but did not affect the QRS or HV shortening produced by NaCI alone. Short-term administration of NaHCO3 or NaCl can partially reverse ODE-induced conduction slowing, which may be an important factor in arrhythmia aggravation. This effect appears to be related to sodium loading itself rather than to concomitant changes in plasma drug concentration, pH, serum potassium concentration, or osmolality. (Circulation 1989;80:994-1002) S odium channel blockers are commonly used antiarrhythmic drugs that can paradoxically aggravate cardiac arrhythmias.1-4The major in vivo effect of sodium channel blockade is cardiac conduction slowing, which is dependent on the plasma concentration of drug, heart rate, resting potential of cardiac cells, and pH5; marked QRS prolongation at usual drug doses and heart rates is seen primarily with class IC agents such as encainide or flecainide.6,7 This class has also been associ-ated with arrhythmias, especially at higher concentrations and in patients with prior myocardial infarctions,8-12 and anecdotal reports have suggested a role for sodium lactate or bicarbonate in such encainide or flecainide toxicity.'3-15 The purpose of this study was to assess the effects of sodium on electrophysiologic changes induced by a class IC sodium channel blocker.
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We used O-desmethyl encainide (ODE), the predominant metabolite of encainide in more than 90% of patients receiving encainide therapy. ODE is approximately 10 times more potent than encainide itself.16-19 Dogs were given ODE as an intravenous loading infusion followed by a maintenance infusion to obtain temporally stable concentrations during the period of study. In addition to NaHCO3, the effects of another sodium salt, NaCl, were evalu- NaCI NaCI NaCI (2 meq/kg) (5 meq/kg) (10 meq/kg) 3 6 NaHCO3 NaHCO3 NaHCO3 (2 meq/kg) (5 meq/kg) (10 meq/kg) 4 6 Respiratory Mannitol --Alkalosis (10 meq/kg) 5 5 NaCl+KCL ----(5 meq/kg NaCI) (KCI infusion) Animals in group 1 were not pretreated with O-desmethyl ecainide (ODE) and served as non-ODE conrols, whereas those in groups 2-5 were pretreated with ODE. Interventions A, B, and C were administered in order and after electrophysiologic parameters had returned to baseline (see text).
ated. Experiments were also conducted to assess the impact of changes in pH, osmolality, and potassium concentration seen with sodium infusion. In this way, potential mechanisms of the interventions in altering ODE effects were evaluated.
Methods
Adult mongrel dogs of either sex were anesthetized with intravenous pentobarbital (30 mg/kg), intubated, and ventilated with room air (Harvard respirator, South Natick, Massachusetts). The right femoral artery was cannulated to continuously monitor blood pressure and to obtain blood samples. The adjacent femoral vein was cannulated to infuse drugs. A bipolar sensing electrode was inserted into the right common carotid artery and advanced to the noncoronary cusp of the aortic valve to obtain His bundle recordings. A pressure monophasic action potential electrode, as described by Franz,20 was placed at the right ventricular apex through the right external jugular vein to measure local repolarization time. In group 2 (NaCl-treated animals), a right thoracotomy was performed, pacing wires were sewn to the right atrial appendage and to the right ventricular epicardium, and the chest was closed. In these animals, QRS and HV data were obtained during constant atrial pacing and during sinus rhythm, and right ventricular effective refractory period changes were assessed. All animals were allowed to stabilize for 60 minutes before any baseline evaluation.
The interventions are listed in Tables 1 and 2 . Animals in group 1 did not recieve ODE, whereas those in groups 2-5 were studied after ODE infusion. ODE was infused at a rate of 80 ,ug/kg/min for 15 minutes followed by a maintenance infusion of 15 Zg/kg/min; interventions were begun 30 minutes after the start of the maintenance infusion. The times of data collection for each intervention are shown in Table 3 . When multiple interventions were assessed in the same animal, at least 30 minutes were allowed to elapse after electrophysiologic parameters had returned to preintervention values before a subsequent intervention was assessed. In animals with epicardial electrodes, atrial pacing was performed with a square-wave stimulus at twice diastolic threshold, 2 msec in duration, and at a cycle length of 300 msec using a Bloom DTU-VANT-100 stimulator. In these animals, recordings were made during spontaneous rhythm and after 90 seconds of atrial stimulation. Right ventricular effective refractory period was measured by inserting increasingly premature beats during eight beat trains of ventricular drive at a cycle length of 300 msec until the premature stimulus did not result in ventricular capture. Data were acquired and recorded on paper using a VR-12 physiologic recorder (Electronics for Medicine, Pleasantville, New York); these included surface electrocardiographic leads, His bundle electrogram, monophasic action potential electrode signal, and arterial blood pressure. The His electrogram was filtered at 30-250 Hz. Blood samples were obtained at baseline and at intervals throughout each experiment for measurement of arterial blood gases and sodium, potassium, and ODE concentrations (Table 3 ). Heparinized arterial blood samples were analyzed for pH, Po2, and Pco2 using a Minolta 360 blood gas analyzer. Ventilator settings were adjusted at the beginning of each experiment and before each intervention to ensure normal arterial pH (7.35-7.45 ) and adequate oxygenation (Po2>60). Sodium and potassium concentrations were analyzed by flame photometry. A high-pressure liquid chromatography assay procedure21 was used to measure plasma concentrations of ODE and of 3methoxy O-desmethyl encainide (MODE), which is another less potent encainide metabolite that is generated by ODE biotransformation.16-19,22MODE concentrations were either below or just above the limits of assay detection (25 ng/ml). Encainide was not detected in these samples.
Data Analysis
Intervals from the serially recorded tracings of the electrocardiogram, His electrogram, and monophasic action potential electrode were measured off-line using a digitizing pad (Summagraphics) interfaced to a microcomputer (IBM AT). The average of at least three complexes was used for each measurement. Statistical analysis was performed with repeated-measures two-way analysis of variance to detect significant differences among multiple means (BMDP software, 2V).23 A p value less than 0.05 was used to reject the null hypothesis of equal means. If the analysis of variance detected significant differences among means, then pairwise analyses were performed by Duncan's multiple range test. Differences between two groups (e.g., right ventricular effective refractory period changes) were analyzed by Student's paired t test. All data in the text and figures are presented as mean±SEM.
Results
Thirty animals (weight [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] kg) were studied. The number of animals in each intervention group is shown in Table 1 . In animals treated with ODE (groups 2-5), the ODE plasma concentration was 448±68 ng/ml at 45 minutes and remained stable during the following 4 hours (Figure 1 ). In these animals, as also shown in Figure 1 , ODE prolonged QRS duration from 62±2 at baseline to 89±2 msec at 45 minutes (p<0.01), and HV interval was prolonged from 27±1 to 50±1 msec (p<0.01). ODE also increased PR, RR, QT, monophasic action potential duration, and right ventricular effective refractory period (Table 4 ).
In animals not treated with ODE (group 1), infusion of either NaCl (5 meq/kg) or NaHCO3 (5 meq/kg) did not alter QRS or HV intervals significantly ( Figure 2 ). In animals treated with ODE, NaCl (group 2) or NaHCO3 (group 3) rapidly reversed ODE-induced QRS and HV prolongation in a dose-dependent manner. The effects of NaCI (5 meq/kg) in an ODE-treated animal are shown in Figure 3 . The dose-dependent effects of NaCl and NaHCO3 in ODE-treated dogs are shown in Table 5 with the 5-meq/kg dose. In contrast, effects on indexes of repolarization (monophasic action potential duration and QT) were greater at the 10 meq/kg dose than at the 5 meq/kg dose. Two animals died with ventricular fibrillation within 10 minutes after receiving NaCl (10 meq/kg, one animal) or NaHCO3 (10 meq/kg, one animal). Therefore, in group 5 (potassium control) experiments outlined below, a dose of 5 meq/kg NaCl was given. The time courses of QRS and HV shortening by 5 meq/kg NaCl or NaHCO3 are presented in Figure 4 . NaCI decreased the QRS interval from 93-+±1 to 78±2 msec (p<0.01) after 5 minutes, whereas the greatest change with NaHCO3 occurred after 10 minutes, from 92±6 to 76±3 msec (p<0.01). QRS and HV intervals returned to baseline for both interventions between 30 and 60 minutes. The effects of NaCl (5 meq/kg) and NaHCO3 (5 meq/kg) on indexes of repolarization (QT, monophasic action potential duration) are shown in Figure 5 . QT and monophasic action potential duration prolonged transiently with both interventions and returned to baseline within 30 minutes. NaCl (5 meq/kg) also prolonged right ventricular effective refractory period Figure 6 ). Plasma ODE concentrations before NaCI (5 meq/kg) or NaHCO3 (5 meq/kg) were 430±60 and 383±36 ng/ml, respectively, and did not change significantly at 60 minutes after the interventions (after 60 minutes: NaCI group, 420± 104 ng/ml; NaHCO3 group, 408±26 ng/ml). A separate series of seven animals was pretreated with ODE and then infused with NaCl (5 meq/kg): plasma ODE before NaCl infusion, 416±+31 ng/ml; plasma ODE 10 minutes after NaCl infusion, 408+±26 ng/ml.
Although both NaCl and NaHCO3 caused acute reversal of ODE-induced conduction slowing, their mechanisms of action were unclear. Both agents were hyperosmotic loads, and both agents also significantly decreased serum potassium concentration (Figure 7) . The latter would be predicted to prolong repolarization, an effect that was seen ( the fast inward sodium current and shorten QRS and HV.5 Therefore, further experiments were performed with NaCl and NaHCO3 to evaluate the contributions of alkalemia, hyperosmolality, and hypokalemia to the results.
In six ODE pretreated animals (group 4), the ventilator rate was increased to cause hyperventilation and respiratory alkalosis. In 15 minutes, the Pco2 decreased from 33±3 to 21±1 (p<0.01), and the pH increased from 7.37±0.02 to 7.49±0.03 (p <0.01). Despite this alkalemia, electrophysiologic parameters including the QRS and HV intervals did not change significantly ( Figure 6 ). Sixty minutes after a return to normal pH, these animals were given a hyperosmotic load of mannitol. A mannitol dosage of 10 mmol/kg was infused to give the same osmotic load as either NaCl (5 meq/kg) or NaHCO3 (5 meq/kg). Mannitol actually worsened the conduction slowing, producing slight QRS and HV interval prolongation, opposite to that of NaCl or NaHCO3. Group 5 animals received ODE and were then given a slow KCI infusion during 15 minutes in addition to NaCl (5 meq/kg). The results are presented in Figure 8 and are compared with results from animals receiving NaCl (5 meq/kg) alone. In contrast to the animals receiving NaCl alone, the serum potassium concentration was stable in those animals receiving supplemental KCl. The QT and monophasic action potential duration prolongation seen in animals receiving NaCl alone was also blunted in animals receiving NaCl with KCl infusion. However, in both groups, QRS and HV intervals shortened similarly.
Changes in heart rate can also modify drug effects on sodium current.5,24 After NaCl (5 meq/kg) administration in ODE pretreated dogs, the sinus cycle length increased from 430±28 to 459±25 msec (NS) after 5 minutes. To evaluate the possibility that the QRS shortening observed with NaCl (5 meq/kg) in AFTER ODE AFTER NaCl (5 in) 5 uEqIlg FIGURE 3 . Representative tracings at baseline (left), after ODE administration (center), and 5 minutes after NaCl infusion (5 meq/kg) (right). NaCl reversed QRS and HVprolongation by ODE. Tracings in all three panels from top to bottom are surface electrocardiogram leads III and I, monophasic action potential electrode tracing, and the His bundle recording. QRS and HV intervals are listed on the tracings. The bar at the top of the figure represents 400 msec. found that NaCl or NaHCO3 also caused transient prolongation of indexes of repolarization (QT and monophasic action potential duration). The increase in right ventricular effective refractory period after NaCI infusion ( Figure 6 ) also probably reflects prolonged repolarization because reversal of sodium channel block alone might be expected to shorten right ventricular effective refractory period. These effects could not be attributed to changes in pH, heart rate, osmolality, or plasma ODE concentration. Moreover, the findings with supplemental potassium infusions indicate that while alterations in repolarization may have been primarily due to the 325 * changes in serum potassium concentration, the reversal of conduction slowing was not. The differences in the dose-response relations for QRS and for monophasic action potential duration or QT shown in Table 5 may also reflect differences in underlying mechanisms. The most likely explanation for reversal of conduction slowing in these experiments is therefore sodium loading itself.
Successful reversal of conduction slowing and cardiac arrhythmias by hypertonic sodium lactate in procainamide or quinidine toxicity were first reported by Bellet et al25,26 and Wasserman et al. 27 Cox and West28 found hypernatremia caused by the addition of NaCl, sodium lactate, or Na2SO4 to be partially effective in reversing the effects of quinidine, including conduction slowing. Nahas et a129 showed the protective effects of hypertonic NaCl in preventing arrhythmias in the model of rapid CO2 washout after hypercapnic acidosis. They theorized a critical sodium to potassium ratio as the protective mechanism. NaHCO3 has also been reported to benefit tricyclic antidepressant toxicity with QRS prolongation,30,32 and a good correlation has been found between marked QRS widening (QRS> 160 msec) and ventricular arrhythmias in tricyclic antidepressant toxicity.33 Infusion of NaHCO3 in amitriptyline-intoxicated dogs with QRS widening and ventricular arrhythmias has been shown to reverse the conduction depression and arrhythmias. 34 Pentel and Benowitz35 found hypernatremia, induced by either NaCI or NaHCO3 infusion, to be effective in reversing desipramine-induced QRS prolongation in rats. The results of our study agree with the in vivo findings of Pentel and Benowitz in which hypernatremia was the major factor in reversing conduction slowing without additional benefit of alkalosis. Nattel and Mittleman36 evaluated the effects of NaHCO3 and NaCI on amitriptyline-induced arrhythmias in dogs. They found NaHCO3 (1-2 meq/kg) or respiratory alkalosis, but not NaCI (1-2 meq/kg), to be effective in terminating or preventing arrhythmias in this model. The doses of NaCl used in our study were larger. The mechanisms by which sodium salts reverse conduction slowing and reverse arrhythmia aggravation may be disparate. Further, the effects of sodium salts may also depend on individual properties of sodium channel blockers such as pKa, lipid solubility, or molecular weight.
In vitro studies have also shown reversal of amitriptyline-induced Vmax depression by NaHCO3. 37 Moreover, NaHCO3 tended to reverse the shift in inactivation caused by amitriptyline, but alone had no effect on inactivation. Kohlhardt38 showed accentuation of tonic and phasic sodium channel blockade with decreased extracellular sodium concentration in the presence of propafenone in guinea pig papillary muscle preparations. A shift in the inactivation curve shift after a decrease in extracellular sodium concentration was also found only in the presence of drug. De Mello39 showed increased intercellular coupling resistance with intracellular acidosis and hypernatremia. Whether or not intracellular alkalosis improves intercellular coupling is not clear; however, increased extracellular sodium KCI infusion (indicated by the black box) in contrast to the hypokalemia in animals receiving NaCl alone. In the animals with NaCl+KCl infusion, monophasic action potential duration (mAPD) prolongation was attenuated, but QRS shortening was similar to that seen in animals receiving NaCl alone. concentration probably does not significantly change the intracellular sodium concentration because of activation of the sodium-potassium pump. Clinical reports have suggested a role for acute sodium loading in encainide or flecainide intoxication, particularly in suicidal overdose and normal hearts. Pentel et a113 reported a case of encainide overdose (3,000 mg) with generalized seizures, obtundation, hypotension, and marked QRS widening (196 msec). Short-term NaHCO3 (100 meq during 2 minutes) promptly improved the hypotension, heart rate, and decreased the QRS interval. A second dose of NaHCO3 (17 minutes after admission) further decreased the QRS interval from 157 to 130 msec. Winkelman and Leinberger14 reported benefits of NaHCO3 (250 mmol) in a case of flecainide intoxication (3,800 mg). Chouty et a115 described three patients with flecainide toxicity who presented with ventricular arrhythmias, hypotension, and markedly prolonged QRS complexes, all of whom were successfully treated with sodium lactate. In one of the three patients, flecainide plasma concentrations were found to be higher 4 hours after receiving sodium lactate than on admission. The possibility that sodium lactate altered flecainide absorption or distribution (e.g., binding to plasma proteins) was suggested. However, we did not find any short-term changes in the ODE concentrations at 10 minutes or at 60 minutes after NaCl (5 meq/kg) or after NaHCO3 (5 meq/kg) infusion.
The degree of hypernatremia achieved in our animals would not be expected to significantly alter driving force for sodium current. For example, an increase of the extracellular sodium concentration from 145 to 160 meq/l would only increase the reversal potential for sodium from 60.3 to 62.9 mV, assuming unchanged intracellular sodium concentration of 15 mM. The resultant increase in the driving force for sodium (ENa, resting potential) would be small and hence unlikely to cause a 15-20% decrease in the QRS interval. This study is consistent with the hypothesis that Na+ ions are important for the interaction between antiarrhythmic drugs and sodium channels as proposed by Kohlhardt.38 The modulation of the ODE-induced sodium channel blockade by Na+ ions could be due to the alterations of sodium channel protein surface charges40 or by Na+ ions directly controlling the access of ODE to its receptor.41 This is partially supported by the shifting of inactivation by altered extracellular sodium concentration only in the presence of sodium channel blockers noted by Kohlhardt38 and Sasyniuk and Jhamandas.37 Increased extracellular sodium concentration may also alter intercellular or intracellular resistivity to accelerate the action potential propagation.
This study evaluated the effects of sodium on a new subclass of antiarrhythmic drugs. These agents routinely increase QRS at therapeutic doses. Arrhythmia aggravation by these agents may be due in part to this marked slowing of conduction velocity; slowed conduction without changes in refractoriness may theoretically enable potential reentrant circuits. Such a hypothesis would explain why patients with remote myocardial infarctions have a high incidence of arrhythmia aggravation, whereas those with structurally normal hearts may tolerate striking QRS widening without worsening of arrhythmias. Although sporadic reports have suggested the benefit of sodium loading in encainide or flecainide toxicity, the overall clinical usefulness of this treatment strategy in the setting of encainide or flecainide toxicity remains unknown.
This study was not designed to evaluate the effects of sodium administration on arrhythmia aggravation by class IC agents but rather to show the reversibility of marked conduction slowing by ODE, which is characteristic of class IC agents. Although marked conduction slowing may be an important factor in arrhythmia aggravation, the results of this study should not yet be extrapolated to patients with arrhythmia aggravation. Hemodynamics in *.
-1------1 1~_ patients with poor left ventricular function or ongoing sustained ventricular arrhythmias may obviously deteriorate during sodium loading. Further clinical evaluation of short-term sodium administration to treat patients with arrhythmia aggravation by sodium channel blockers is needed before this potentially dangerous therapy can be universally recommended. Further studies should also focus on the mechanism whereby increased extracellular sodium concentration improves conduction in the presence of potent sodium channel blocking drugs. Delineation of such a mechanism may then allow development of more specific agents for clinical use in the setting of excessive sodium channel blockade, conduction slowing, and arrhythmia aggravation.
